Showing results (1771-1780 of 1,873) with videos related to
Sort By:
Pageof 188
Biorxiv : the Preprint Server for Biology|March 23, 2026
Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancerClemens Hinterleitner, Valentin J A Barthet, Hailey V Goldberg, et al.Biorxiv : the Preprint Server for Biology|July 10, 2023
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancerRay Pillai, Sarah E LeBoeuf, Yuan Hao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2021
KRAS G12C Mutation Is Associated with Increased Risk of Recurrence in Surgically Resected Lung AdenocarcinomaGregory D Jones, Raul Caso, Kay See Tan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2026
Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non-Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART)Andreas Rimner, Emily S Lebow, Kelly J Fitzgerald, et al.Oncotarget|October 29, 2013
Alterations of immune response of Non-Small Cell Lung Cancer with AzacytidineJohn Wrangle, Wei Wang, Alexander Koch, et al.Cancer Discovery|July 5, 2022
PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral MimicryAmish J Patel, Sarah Warda, Jesper L V Maag, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2023
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerRohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, et al.The New England Journal of Medicine|September 29, 2015
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung CancerHossein Borghaei, Luis Paz-Ares, Leora Horn, et al.International Journal of Radiation Oncology, Biology, Physics|March 8, 2023
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation PneumonitisAndreas Rimner, Zachary R Moore, Stephanie Lobaugh, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2024
Lung cancer research and treatment: global perspectives and strategic calls to actionM-L Meyer, S Peters, T S Mok, et al.Pageof 188